Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Visceral adipose tissue and carotid intima-media thickness in HIV-infected patients undergoing cART: a prospective cohort study

Authors: Maria Teresa Beires, André Silva-Pinto, Ana Cristina Santos, António José Madureira, Jorge Pereira, Davide Carvalho, António Sarmento, Paula Freitas

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Combined antiretroviral therapy (cART) in HIV-infected patients has been associated with lipodystrophy, metabolic abnormalities, and an increased risk of cardiovascular disease. Ultrasound measures of carotid artery intima-media thickness (cIMT) have been used as a valid measure of subclinical atherosclerosis and as a tool to predict the risk of cardiovascular events. Our aim was to evaluate the progression of cIMT in HIV-infected patients subjected to cART, with and without lipodystrophy, over a one-year period.

Methods

We performed a one-year prospective cohort study to compare changes in cIMT, metabolic and inflammation markers in HIV-infected patients undergoing cART. Body composition was assessed by dual-energy X-ray absorptiometry (DXA) and abdominal computed tomography (CT). Levels of blood pressure, lipids and inflammatory markers were evaluated, as well as ultrasound measures of cIMT. Lipodystrophy defined by Fat Mass Ratio (L-FMR) is measured as the ratio of the percentage of trunk fat mass to the percentage of lower limb fat mass by DXA. Categorical variables were compared, using the chi-square or Fisher’s exact test. Wilcoxon ranks tests and the McNemar chi-square tests were used to compare results of selected variables, from the first to the second year of evaluation. Means of cIMT, adjusted for age, glucose, triglycerides levels, systolic blood pressure (SBP), and waist to hip ratio were calculated, using generalised linear models for repeated measures.

Results

L-FMR was present in 44.3% of patients, and the mean of cIMT increased significantly in this group [0.82 (0.26) vs 0.92 (0.33); p = 0.037], as well as in patients without lipodystrophy [0.73 (0.20) vs 0.84 (0.30); p = 0.012]. In the overall sample, the progression of cIMT was statistically significant after the adjustment for age, glucose, triglycerides, and SBP, but the significance of the progression ceased after the adjustment for waist/hip ratio [0.770 (0.737–0.803) vs 0.874 (0.815–0.933); p = 0.514].

Conclusions

Carotid IMT progressed significantly in both groups of this HIV-infected cohort, however no association between the progression of cIMT and the presence of lipodystrophy defined by FMR was found. Visceral adipose tissue had an impact on the increment of cIMT, both in patients with, and without lipodystrophy defined by FMR.
Literature
1.
go back to reference Hogg R, Lima V, Sterne JA, Grabar S, Battegay M, Bonarek M, D'Arminio Monforte A, Esteve A, Gill MJ, Harris R, Justice A, Hayden A, Lampe F, Mocroft A, Mugavero MJ, Staszewski S, Wasmuth JC, van Sighem A, Kitahata M, Guest J, Egger M, May M. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293–9.CrossRef Hogg R, Lima V, Sterne JA, Grabar S, Battegay M, Bonarek M, D'Arminio Monforte A, Esteve A, Gill MJ, Harris R, Justice A, Hayden A, Lampe F, Mocroft A, Mugavero MJ, Staszewski S, Wasmuth JC, van Sighem A, Kitahata M, Guest J, Egger M, May M. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293–9.CrossRef
2.
go back to reference Palella FJ, Delaney KM, Moorman AC, Loveles MO, Fuher J, SattenGA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV outpatient study investigators. N Engl J Med 1998;338:853–860. Palella FJ, Delaney KM, Moorman AC, Loveles MO, Fuher J, SattenGA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV outpatient study investigators. N Engl J Med 1998;338:853–860.
3.
go back to reference Lichtenstein KA. Redefining lipodystrophy syndrome: risks and impact on clinical decision making. J Acquir Immune Defic Syndr. 2005;39(4):395–400.CrossRefPubMed Lichtenstein KA. Redefining lipodystrophy syndrome: risks and impact on clinical decision making. J Acquir Immune Defic Syndr. 2005;39(4):395–400.CrossRefPubMed
4.
go back to reference Brown TT, Li X, Cole SR, Kingsley LA, Palella FJ, Riddler SA, Chimel JS, Visscher BR, Margolick JB, Dobs AS. Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the multicenter AIDS cohort study. AIDS. 2005;19(13):1375–83.CrossRefPubMed Brown TT, Li X, Cole SR, Kingsley LA, Palella FJ, Riddler SA, Chimel JS, Visscher BR, Margolick JB, Dobs AS. Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the multicenter AIDS cohort study. AIDS. 2005;19(13):1375–83.CrossRefPubMed
5.
go back to reference van Vonderen MGA, Smulders YM, Stehouwer CD, Danner SA, Gundy CM, Vos F, Reiss P, van Agtmael MA. Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy and Lipodystrophy. J Acquir Immune Defic Syndr. 2009;50:153–61.CrossRefPubMed van Vonderen MGA, Smulders YM, Stehouwer CD, Danner SA, Gundy CM, Vos F, Reiss P, van Agtmael MA. Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy and Lipodystrophy. J Acquir Immune Defic Syndr. 2009;50:153–61.CrossRefPubMed
6.
go back to reference Freitas P, Carvalho D, Santos AC, Madureira AJ, Martinez E, Pereira J, Sarmento A, Medina JL. Carotid intima media thickness is associated with body fat abnomarlities in HIV-infected patients. BMC Infect Dis. 2014;14:348–56.CrossRefPubMedPubMedCentral Freitas P, Carvalho D, Santos AC, Madureira AJ, Martinez E, Pereira J, Sarmento A, Medina JL. Carotid intima media thickness is associated with body fat abnomarlities in HIV-infected patients. BMC Infect Dis. 2014;14:348–56.CrossRefPubMedPubMedCentral
7.
go back to reference Castro KG, Ward JW, Slutsker L, Buehler JW, Jaffe HW, Berkelman RL. National Center for infectious diseases division of HIV/AIDS: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep. 1992;41:1–19. Castro KG, Ward JW, Slutsker L, Buehler JW, Jaffe HW, Berkelman RL. National Center for infectious diseases division of HIV/AIDS: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep. 1992;41:1–19.
8.
go back to reference Freitas P, Carvalho D, Santos AC, Mesquita J, Correia F, Xerinda S, Marques R, Martinez E, Sarmento A, Medina JL. Assessment of body fat composition disturbances by bioimpedance analysis in HIV-infected adults. J Endocrinol Investig. 2011;34(10):e321–9. Freitas P, Carvalho D, Santos AC, Mesquita J, Correia F, Xerinda S, Marques R, Martinez E, Sarmento A, Medina JL. Assessment of body fat composition disturbances by bioimpedance analysis in HIV-infected adults. J Endocrinol Investig. 2011;34(10):e321–9.
9.
go back to reference WHO: Physical Status: The Use And Interpretation Of Anthropometry. In Report of a WHO Expert Committee. Geneva: World Health Organization;1995. WHO: Physical Status: The Use And Interpretation Of Anthropometry. In Report of a WHO Expert Committee. Geneva: World Health Organization;1995.
10.
go back to reference Freitas P, Carvalho D, Souto S, Santos AC, Xerinda S, Marques R, Martinez E, Sarmento A, Medina JL. Impact of lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients. BMC Infect Dis. 2011;11(1):246.CrossRefPubMedPubMedCentral Freitas P, Carvalho D, Souto S, Santos AC, Xerinda S, Marques R, Martinez E, Sarmento A, Medina JL. Impact of lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients. BMC Infect Dis. 2011;11(1):246.CrossRefPubMedPubMedCentral
11.
go back to reference Bonnet E, Delpierre C, Sommet A, Marion-Latard F, Herve R, Aquilina C, Labau E, Obadia M, Marchou B, Massip P, Perret B, Bernard J. Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy. J Clin Densitom. 2005;8(3):287–92.CrossRefPubMed Bonnet E, Delpierre C, Sommet A, Marion-Latard F, Herve R, Aquilina C, Labau E, Obadia M, Marchou B, Massip P, Perret B, Bernard J. Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy. J Clin Densitom. 2005;8(3):287–92.CrossRefPubMed
12.
go back to reference Freitas P, Santos AC, Carvalho D, Pereira J, Marques R, Martinez E, Sarmento A, Medina JL. Fat mass ratio: an objective tool to define lipodystrophy in HIV-infected patients under antiretroviral therapy. J Clin Densitom. 2010;13(2):197–203.CrossRefPubMed Freitas P, Santos AC, Carvalho D, Pereira J, Marques R, Martinez E, Sarmento A, Medina JL. Fat mass ratio: an objective tool to define lipodystrophy in HIV-infected patients under antiretroviral therapy. J Clin Densitom. 2010;13(2):197–203.CrossRefPubMed
13.
go back to reference Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, Arai T, Kotani K, Funahashi T, Yamashita S, Yoshizumi T, Matsuzawa Y. Abdominal fat: standardised technique for measurement at CT. Radiology. 1999;211(1):283–6.CrossRefPubMed Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, Arai T, Kotani K, Funahashi T, Yamashita S, Yoshizumi T, Matsuzawa Y. Abdominal fat: standardised technique for measurement at CT. Radiology. 1999;211(1):283–6.CrossRefPubMed
14.
go back to reference van der Kooy K, Seidell JC. Techniques for measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord. 1993;17(4):187–96.PubMed van der Kooy K, Seidell JC. Techniques for measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord. 1993;17(4):187–96.PubMed
15.
go back to reference World Health Organization: Definition, Diagnosis and Classification Of Diabetes Mellitus And Its Complications. In Report of WHO Consulation. Geneva;1999. World Health Organization: Definition, Diagnosis and Classification Of Diabetes Mellitus And Its Complications. In Report of WHO Consulation. Geneva;1999.
16.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell functions from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell functions from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.CrossRefPubMed
17.
go back to reference Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002, P106-P3143. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002, P106-P3143.
18.
go back to reference Polak JF, O’Leary DH, Kronmal RA, Wolfson SK, Bond MG, Tracy RP, Gardin JM, Kittner SJ, Price TR, Savage PJ. Sonographic evaluation of carotid artery atherosclerosis in the elderly: relationship of disease severity to stroke and transient ischemic attack. Radiology. 1993;188(2):363–70.CrossRefPubMed Polak JF, O’Leary DH, Kronmal RA, Wolfson SK, Bond MG, Tracy RP, Gardin JM, Kittner SJ, Price TR, Savage PJ. Sonographic evaluation of carotid artery atherosclerosis in the elderly: relationship of disease severity to stroke and transient ischemic attack. Radiology. 1993;188(2):363–70.CrossRefPubMed
19.
go back to reference O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group. N Engl J Med. 1999;340(1):14–22.CrossRefPubMed O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group. N Engl J Med. 1999;340(1):14–22.CrossRefPubMed
20.
go back to reference Mangili A, Jacobson DL, Gerrior J, Polak JF, Gorbach SL, Wanke CA. Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV. Clin Infect Dis. 2007;44(10):1368–74.CrossRefPubMedPubMedCentral Mangili A, Jacobson DL, Gerrior J, Polak JF, Gorbach SL, Wanke CA. Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV. Clin Infect Dis. 2007;44(10):1368–74.CrossRefPubMedPubMedCentral
21.
go back to reference Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999 Sep 28;100(13):1481–92.CrossRefPubMed Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999 Sep 28;100(13):1481–92.CrossRefPubMed
22.
go back to reference Rose KA, Vera J, Drivas P, Banya W, Keenan N, Pennell DJ, Winston A. Atherosclerosis is evident in treated HIV-infected subjects with low cardiovascular risk by carotid cardiovascular magnetic resonance. J Acquir Immune Defic Syndr. 2016;71(5):514–21.CrossRefPubMedPubMedCentral Rose KA, Vera J, Drivas P, Banya W, Keenan N, Pennell DJ, Winston A. Atherosclerosis is evident in treated HIV-infected subjects with low cardiovascular risk by carotid cardiovascular magnetic resonance. J Acquir Immune Defic Syndr. 2016;71(5):514–21.CrossRefPubMedPubMedCentral
23.
go back to reference Samanta S, Balasubramanian S, Rajasingh S, Patel U, Dhanasekaran A, Dawn B, Rajasingh J. MicroRNA: a new therapeutic strategy for cardiovascular diseases. Trends Cardiovasc Med. 2016;26(5):407–19.CrossRefPubMedPubMedCentral Samanta S, Balasubramanian S, Rajasingh S, Patel U, Dhanasekaran A, Dawn B, Rajasingh J. MicroRNA: a new therapeutic strategy for cardiovascular diseases. Trends Cardiovasc Med. 2016;26(5):407–19.CrossRefPubMedPubMedCentral
24.
go back to reference Friis-Moller N, Sabin CA, Weber R, d’Arminio Monforte A, El-Sadr WM, Reiss P, Thiebaut R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349(21):1993–2003.CrossRefPubMed Friis-Moller N, Sabin CA, Weber R, d’Arminio Monforte A, El-Sadr WM, Reiss P, Thiebaut R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349(21):1993–2003.CrossRefPubMed
25.
go back to reference Grinspoon S, Carr A, et al. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352(1):48–62.CrossRefPubMed Grinspoon S, Carr A, et al. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352(1):48–62.CrossRefPubMed
26.
go back to reference Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the atherosclerosis risk in communities (ARIC) study, 1987–1993. Am J Epidemiol. 1997;146:483–94.CrossRefPubMed Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the atherosclerosis risk in communities (ARIC) study, 1987–1993. Am J Epidemiol. 1997;146:483–94.CrossRefPubMed
27.
go back to reference Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation. 1997;96:1432–7.CrossRefPubMed Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation. 1997;96:1432–7.CrossRefPubMed
28.
go back to reference Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 1993;87(Suppl 3):II56–65.PubMed Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 1993;87(Suppl 3):II56–65.PubMed
29.
go back to reference Stein JH, Currier JS, Hsue PY. Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us? JACC Cardiovascular imaging. 2014;7(5):515–25.CrossRefPubMedPubMedCentral Stein JH, Currier JS, Hsue PY. Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us? JACC Cardiovascular imaging. 2014;7(5):515–25.CrossRefPubMedPubMedCentral
30.
go back to reference Kaplan RC, Kingsley LA, Gange SJ, Benning L, Jacobson LP, Lazar J, et al. Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS. 2008;22(13):1615–24.CrossRefPubMedPubMedCentral Kaplan RC, Kingsley LA, Gange SJ, Benning L, Jacobson LP, Lazar J, et al. Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS. 2008;22(13):1615–24.CrossRefPubMedPubMedCentral
31.
go back to reference Mercier P, Thiebaut R, Lavingnolle V, Pellegrin JL, Yvorra-Vives MC, Morlat P, Ragnaud JM, Dupon M, Malvy D, Bellet H, et al. Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement. Ann Med. 2002;34(1):55–63.CrossRef Mercier P, Thiebaut R, Lavingnolle V, Pellegrin JL, Yvorra-Vives MC, Morlat P, Ragnaud JM, Dupon M, Malvy D, Bellet H, et al. Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement. Ann Med. 2002;34(1):55–63.CrossRef
32.
go back to reference Volpe GE, Tang AM, Polak JF, Mangili A, Skinner SC, Wanke CA. Progression of carotid intima media thickness and coronary artery calcium over 6 years in an HIV- infected cohort. J Acquir Immune Defic Syndr. 2013;64:51–7.CrossRefPubMed Volpe GE, Tang AM, Polak JF, Mangili A, Skinner SC, Wanke CA. Progression of carotid intima media thickness and coronary artery calcium over 6 years in an HIV- infected cohort. J Acquir Immune Defic Syndr. 2013;64:51–7.CrossRefPubMed
33.
go back to reference Hanna DB, Post WS, Deal JA, Hodis HN, Jacobson LP, Mack WJ, et al. HIV infection is associated with progression of subclinical carotid atherosclerosis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2015;61(4):640–50.CrossRef Hanna DB, Post WS, Deal JA, Hodis HN, Jacobson LP, Mack WJ, et al. HIV infection is associated with progression of subclinical carotid atherosclerosis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2015;61(4):640–50.CrossRef
34.
go back to reference Baker JV, Henry WK, Patel P, et al. Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort. Clin Infect Dis. 2011;53:826–35.CrossRefPubMedPubMedCentral Baker JV, Henry WK, Patel P, et al. Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort. Clin Infect Dis. 2011;53:826–35.CrossRefPubMedPubMedCentral
35.
go back to reference Hsue PY, Hunt PW, Schnell A, et al. Role of viral replication antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS. 2009;23:1059–67.CrossRefPubMedPubMedCentral Hsue PY, Hunt PW, Schnell A, et al. Role of viral replication antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS. 2009;23:1059–67.CrossRefPubMedPubMedCentral
36.
go back to reference Sankatsing RR, Wit FW, Vogel M, de Groot E, Brinkman K, Rockstroh JK, Kastelein JJ, Stroes ES, Reiss P. Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitors. Atherosclerosis. 2009;202(2):589–95.CrossRefPubMed Sankatsing RR, Wit FW, Vogel M, de Groot E, Brinkman K, Rockstroh JK, Kastelein JJ, Stroes ES, Reiss P. Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitors. Atherosclerosis. 2009;202(2):589–95.CrossRefPubMed
37.
go back to reference de Saint ML, Vandhuick O, Guillo P, Bellein V, Bressollette L, Roudaut N, Amaral A, Pasquier E. Premature atherosclerosis in HIV positive patients and cumulate time of exposure to antiretroviral therapy (SHIVA study). Atherosclerosis. 2006;185(2):361–7.CrossRef de Saint ML, Vandhuick O, Guillo P, Bellein V, Bressollette L, Roudaut N, Amaral A, Pasquier E. Premature atherosclerosis in HIV positive patients and cumulate time of exposure to antiretroviral therapy (SHIVA study). Atherosclerosis. 2006;185(2):361–7.CrossRef
38.
go back to reference Bongiovanni M, Casana M, Cicconi P, Pisacreta M, Codemo R, Pelucchi M, d’Arminio Monforte A, Bini T. Predicteve factors of vascular intima media thickness in HIV positive subjects. J Antimicrob Chemother. 2008;61(1):195–9.CrossRefPubMed Bongiovanni M, Casana M, Cicconi P, Pisacreta M, Codemo R, Pelucchi M, d’Arminio Monforte A, Bini T. Predicteve factors of vascular intima media thickness in HIV positive subjects. J Antimicrob Chemother. 2008;61(1):195–9.CrossRefPubMed
39.
go back to reference Py H, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, Walters DD. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation. 2004;109(13):1603–8.CrossRef Py H, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, Walters DD. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation. 2004;109(13):1603–8.CrossRef
40.
go back to reference Huber HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation. 1983;67(5):968–77.CrossRef Huber HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation. 1983;67(5):968–77.CrossRef
41.
go back to reference Burke GL, Bertoni AG, Shea S, Tracy R, Watson KE, Blumenthal RS, Chung H, Carnethon MR. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the multi-ethnic study of atherosclerosis. Arch Intern Med. 2008;168(9):928–35.CrossRefPubMedPubMedCentral Burke GL, Bertoni AG, Shea S, Tracy R, Watson KE, Blumenthal RS, Chung H, Carnethon MR. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the multi-ethnic study of atherosclerosis. Arch Intern Med. 2008;168(9):928–35.CrossRefPubMedPubMedCentral
Metadata
Title
Visceral adipose tissue and carotid intima-media thickness in HIV-infected patients undergoing cART: a prospective cohort study
Authors
Maria Teresa Beires
André Silva-Pinto
Ana Cristina Santos
António José Madureira
Jorge Pereira
Davide Carvalho
António Sarmento
Paula Freitas
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2884-9

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue